Literature DB >> 9637580

Longitudinal HIV-1 RNA levels in a cohort of homosexual men.

T R O'Brien1, P S Rosenberg, F Yellin, J J Goedert.   

Abstract

HIV-1 RNA levels measured during early chronic infection strongly predict subsequent clinical events. In the short term, HIV-1 is in a steady state, but the stability of viral levels over time is incompletely understood. We used reverse transcriptase polymerase chain reaction (RT-PCR) to examine changes in serum HIV-1 RNA levels in 111 HIV-1-infected homosexual men during the period from 1982 to 1992 and their relation to clinical outcomes. HIV-1 RNA levels increased by a median of 0.08 log10 copies/ml/year (p=.0001). HIV-1 RNA levels rose either gradually or abruptly for the majority of subjects; 41% had no increase. Among subjects surviving at least 8 years, HIV-1 RNA was stable during the first 4 years after seroconversion (median. 0.00 log10 copies/ml/year), but rose in years five through eight (median, 0.06 log10 copies/ml/year; p=.04). The annual HIV-I RNA level was more predictive of AIDS (relative hazard [RH], 1.75 per 0.5 log difference; 95% confidence interval [CI], 1.38-2.21; likelihood ratio [LR], 26.2) than the initial level alone (RH, 1.39; 95% CI. 1.10-1.76; LR, 8.5). We conclude that most HIV-1-infected persons lack a long-term viral setpoint and that failure to account for evolution of the viral level can lead to underestimation of the risk of progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9637580     DOI: 10.1097/00042560-199806010-00007

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  18 in total

1.  A simple relationship between viral load and survival time in HIV-1 infection.

Authors:  R A Arnaout; A L Lloyd; T R O'Brien; J J Goedert; J M Leonard; M A Nowak
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.

Authors:  Soo-Jin Cho; Henning Drechsler; Ryan C Burke; Max Q Arens; William Powderly; Nicholas O Davidson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Precise determination of time to reach viral load set point after acute HIV-1 infection.

Authors:  Xiaojie Huang; Hui Chen; Wei Li; Haiying Li; Xia Jin; Alan S Perelson; Zoe Fox; Tong Zhang; Xiaoning Xu; Hao Wu
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

4.  Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes.

Authors:  Xia Jin; Xiaojiang Gao; Murugappan Ramanathan; Geoffrey R Deschenes; George W Nelson; Stephen J O'Brien; James J Goedert; David D Ho; Thomas R O'Brien; Mary Carrington
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Pseudo maximum likelihood approach for the analysis of multivariate left-censored longitudinal data.

Authors:  Ghideon Solomon; Lisa Weissfeld
Journal:  Stat Med       Date:  2016-08-18       Impact factor: 2.373

6.  Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Elias Woldegabriel; Lemme Kebaabetswe; Raabya Rossenkhan; Busisiwe Mlotshwa; Caitlin Bonney; Mariel Finucane; Rosemary Musonda; Sikhulile Moyo; Carolyn Wester; Erik van Widenfelt; Joseph Makhema; Stephen Lagakos; M Essex
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

7.  Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village.

Authors:  Maarten F Schim van der Loeff; Natasha Larke; Steve Kaye; Neil Berry; Koya Ariyoshi; Abraham Alabi; Carla van Tienen; Aleksandra Leligdowicz; Ramu Sarge-Njie; Zacharias da Silva; Assan Jaye; Dominique Ricard; Tim Vincent; Sarah Rowland Jones; Peter Aaby; Shabbar Jaffar; Hilton Whittle
Journal:  Retrovirology       Date:  2010-05-19       Impact factor: 4.602

8.  Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus.

Authors:  Miles P Davenport; Ruy M Ribeiro; Dennis L Chao; Alan S Perelson
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 9.  Modeling antiretroviral drug responses for HIV-1 infected patients using differential equation models.

Authors:  Yanni Xiao; Hongyu Miao; Sanyi Tang; Hulin Wu
Journal:  Adv Drug Deliv Rev       Date:  2013-04-17       Impact factor: 15.470

10.  Cost-effectiveness of HIV screening in patients older than 55 years of age.

Authors:  Gillian D Sanders; Ahmed M Bayoumi; Mark Holodniy; Douglas K Owens
Journal:  Ann Intern Med       Date:  2008-06-17       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.